Drug Trial Radar · NCT07695701
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Jul 28, 2026
Primary completion
Aug 2030
Study completion Nov 2030
Sponsor
- Lead sponsor
- Eidos Therapeutics, a BridgeBio companyIndustry
- Sponsor type
- Industry
- First posted
- Jul 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aims to evaluate the effect of acoramidis on cardiac functional and structural improvement in participants with ATTR-CM.
Conditions
- Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
- Amyloidosis
- Amyloid Cardiomyopathy
- Transthyretin Amyloidosis
Interventions
Acoramidis (AG10) oral tabletDrug
Study drug is defined as acoramidis 712 mg (equivalent to 800 mg acoramidis hydrochloride) taken orally twice daily for 36 months of open label treatment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the effect of acoramidis on cardiac function improvement by CMR in participants with ATTR-CM.Time frame: Month 36
Locations
9 sites in 3 countries. Site status is shown where the registry gives one.
Johns Hopkins University 056
Baltimore, Maryland · Recruiting
Washington University in St. Louis - 065
St Louis, Missouri · Recruiting
Philadelphia Heart Institute - 030
Philadelphia, Pennsylvania · Recruiting
National Heart Centre - Singapore - 418
Singapore, Singapore · Recruiting
Hospital Universitari de Bellvitge 249
Barcelona, Spain · Recruiting
Hospital Universitario Juan Ramon Jimenez - 237
Huelva, Spain · Recruiting
Hospital Clinico Universitario de Salamanca - 236
Salamanca, Spain · Recruiting
Hospital Universitario Son Llatzer - 224
Son Ferriol, Spain · Recruiting
Hospital Universitario Puerta de Hierro - 203
Majadahonda, Madrid, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.